CFO
Konapharma, Switzerland
Patrik Spirig
B.A. (HSG) in Business Administration, M.A. (HSG) in Accounting & Finance
Since 2017 Patrik is CFO of Konapharma AG, a Swiss-based pharmaceutical CDMO. His responsibilities also include company and pharmaceutical product acquisitions, licensing deals and co-investments in pharmaceutical product developments, including the respecive due diligence processes in these transactions.
From 2011 to 2017 Patrik worked as Transaction Manager in the Mergers & Acquisitions team of the UBS Switzerland Corporate Finance department. This involved financial lead advisory on mergers, sell-side & buy-side transactions, leveraged buy-out's, carve-out's, distressed sales or valuation project for mid-sided companies in various industries. Due Diligence processes and considerations were also here an important part in the daily tasks.
Before that Patrik gained experience at Ernst & Young in financial auditing and at the M&A advisory boutique TCO Transition Company.
Disclosure information not submitted.
Friday, May 12, 2023
14:00 – 15:00 CEST